The expression of VCAM-1 has been proposed as a biomarker in immunological diseases (experimental autoimmune myocarditis), as a predictor of mortality and morbidity in patients with chronic heart failure, and in those with endothelial injury in patients with coronary artery disease and arrhythmia. This evidence concerns the gene VCAM1 and cardiac arrhythmia.